Abiopharma

American Gold and Copper Inc. (formerly Everlert, Inc.) is a mineral exploration and resource development company focused on the acquisition, exploration, advancement, and development of copper, gold, and other strategic mineral properties, primarily in South America. The Companys strategy is to identify high-potential mineral assets with significant exploration upside, apply disciplined technical evaluation and modern exploration practices, and create long-term shareholder value through resource development, strategic partnerships, and potential production opportunities. The Company continues to evaluate additional acquisitions that complement its growing portfolio of mineral assets. Everlert, Inc. recently completed a corporate name change to American Gold and Copper Inc. with the State of Nevada and is in the process of completing the related corporate action with FINRA, after which the Companys OTC Markets profile and trading symbol will be updated accordingly.

Additional info from OTC:
American Gold and Copper Inc. (formerly Everlert, Inc.) is a mineral exploration and resource development company focused on the acquisition, exploration, advancement, and development of copper, gold, and other strategic mineral properties, primarily in South America. The Companys strategy is to identify high-potential mineral assets with significant exploration upside, apply disciplined technical evaluation and modern exploration practices, and create long-term shareholder value through resource development, strategic partnerships, and potential production opportunities. The Company continues to evaluate additional acquisitions that complement its growing portfolio of mineral assets. Everlert, Inc. recently completed a corporate name change to American Gold and Copper Inc. with the State of Nevada and is in the process of completing the related corporate action with FINRA, after which the Companys OTC Markets profile and trading symbol will be updated accordingly.